Page last updated: 2024-08-18

thiophenes and Ascites

thiophenes has been researched along with Ascites in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belotti, D; Garofalo, A; Giavazzi, R; Manenti, L; Marchini, S; Paganoni, P; Taraboletti, G1
Brown, PD; Talbot, DC1
Parsons, SL; Steele, RJ; Watson, SA1
Beattie, GJ; Smyth, JF1
Bone, EA; Dickson, RB; Johnson, MD; Low, JA1

Reviews

1 review(s) available for thiophenes and Ascites

ArticleYear
Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:14

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Ascites; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Extracellular Matrix; Female; Humans; Male; Metalloendopeptidases; Mice; Middle Aged; Neoplasms; Phenylalanine; Pleural Effusion, Malignant; Protease Inhibitors; Rats; Thiophenes

1996

Trials

2 trial(s) available for thiophenes and Ascites

ArticleYear
Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1997, Volume: 23, Issue:6

    Topics: Aged; Antineoplastic Agents; Ascites; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Metalloendopeptidases; Middle Aged; Phenylalanine; Protease Inhibitors; Thiophenes; Treatment Outcome

1997
Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:8

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Dose-Response Relationship, Drug; Female; Humans; Male; Metalloendopeptidases; Middle Aged; Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes

1998

Other Studies

3 other study(ies) available for thiophenes and Ascites

ArticleYear
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
    Cancer research, 2003, Sep-01, Volume: 63, Issue:17

    Topics: Animals; Ascites; Cell Movement; Culture Media, Conditioned; Endothelial Growth Factors; Enzyme Activation; Female; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Ovarian Neoplasms; Peritoneal Cavity; Phenylalanine; Thiophenes; Transplantation, Heterologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:7

    Topics: Animals; Antineoplastic Agents; Ascites; Female; Gelatinases; Humans; Mammary Neoplasms, Experimental; Metalloendopeptidases; Mice; Mice, Nude; Neoplasm Transplantation; Phenylalanine; Protease Inhibitors; Thiophenes; Transplantation, Heterologous; Tumor Cells, Cultured

1996
Batimastat. BB 94, collagenase inhibitors-1.
    Drugs in R&D, 1999, Volume: 1, Issue:2

    Topics: Animals; Antineoplastic Agents; Ascites; Drugs, Investigational; Humans; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Mice; Neoplasms; Phenylalanine; Pleural Effusion, Malignant; Protease Inhibitors; Thiophenes

1999